The effect of artichoke leaf extract supplementation on lipid and CETP response in metabolic syndrome with respect to Taq 1B CETP polymorphism: A randomized placebo-controlled clinical trial

European Journal of Integrative Medicine

Volumn 17, Issue , 2018, Pages 112-118

  Rezazadeh, Khatereh ^a,c   Rezazadeh, Farzin ^b   Ebrahimi Mameghani, Mehranghiz ^c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Artichoke leaf extract; Cholesterol ester transfer protein; Lipid profile; Metabolic syndrome; Randomised controlled trial; Taq IB polymorphism

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; TAQ IB POLYMERASE; TAQ POLYMERASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICHOKE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; GENOTYPE; HETEROZYGOTE; HUMAN; INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PLANT LEAF; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; TABLET; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 85039747923     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2017.12.008     Document Type: Article

References (42)

1. Salem, M.B., Affes, H., Ksouda, K., Dhouibi, R., Sahnoun, Z., Hammami, S., et al. Pharmacological studies of artichoke leaf extract and their health benefits. Plant Foods Hum. Nutr. 70:4 (2015), 441–453.
2. Gebhardt, R., Fausel, M., Antioxidant and hepatoprotective effects of artichoke extracts and constituents in cultured rat hepatocytes. Toxicol. In Vitro 11:5 (1997), 669–672.
3. Zhu, X., Zhang, H., Lo, R., Phenolic compounds from the leaf extract of artichoke (Cynara scolymus L.) and their antimicrobial activities. J. Agric. Food Chem. 52:24 (2004), 7272–7278.
4. Xia, N., Pautz, A., Wollscheid, U., Reifenberg, G., Förstermann, U., Li, H., Artichoke, cynarin and cyanidin downregulate the expression of inducible nitric oxide synthase in human coronary smooth muscle cells. Molecules 19:3 (2014), 3654–3668.
5. Rezazadeh, K., Aliashrafi, S., Asghari-Jafarabadi, M., Ebrahimi-Mameghani, M., Antioxidant response to artichoke leaf extract supplementation in metabolic syndrome: a double-blind placebo-controlled randomized clinical trial. Clin. Nutr., 2017, 10.1016/j.clnu.2017.03.017 (in press).
6. Fantini, N., Colombo, G., Giori, A., Riva, A., Morazzoni, P., Bombardelli, E., et al. Evidence of glycemia-lowering effect by a Cynara scolymus L. extract in normal and obese rats. Phytother. Res. 25:3 (2011), 463–466.
7. Rondanelli, M., Opizzi, A., Faliva, M., Sala, P., Perna, S., Riva, A., et al. Metabolic management in overweight subjects with naive impaired fasting glycaemia by means of a highly standardized extract from cynara scolymus: a double-blind, placebo-controlled, randomized clinical trial. Phytother. Res. 28:1 (2014), 33–41.
8. Nadova, S., Miadokova, E., Mucaji, P., Grancai, D., Cipak, L., Growth inhibitory effect of ethyl acetate-soluble fraction of Cynara cardunculus L. in leukemia cells involves cell cycle arrest, cytochrome c release and activation of caspases. Phytother. Res. 22:2 (2008), 165–168.
9. Englisch, W., Beckers, C., Unkauf, M., Ruepp, M., Zinserling, V., Efficacy of artichoke dry extract in patients with hyperlipoproteinemia. Arzneimittelforschung 50:03 (2000), 260–265.
10. Bundy, R., Walker, A.F., Middleton, R.W., Wallis, C., Simpson, H.C., Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo controlled trial. Phytomedicine 15:9 (2008), 668–675.
11. Wider, B., Pittler, M.H., Thompson-Coon, J., Ernst, E., Artichoke leaf extract for treating hypercholesterolaemia. Cochrane Database Syst. Rev.(3), 2013, 10.1002/14651858.CD003335.pub3.
12. Gebhardt, R., Anticholestatic activity of flavonoids from artichoke (Cynara scolymus L.) and of their metabolites. Med. Sci. Monit. 7 (2001), 316–320.
13. Gebhardt, R., Inhibition of cholesterol biosynthesis in HepG2 cells by artichoke extracts is reinforced by glucosidase pretreatment. Phytother. Res. 16:4 (2002), 368–372.
14. Wang, M., Simon, J.E., Aviles, I.F., He, K., Zheng, Q.-Y., Tadmor, Y., Analysis of antioxidative phenolic compounds in artichoke (Cynara scolymus L.). J. Agric. Food Chem. 51:3 (2003), 601–608.
15. Rondanelli, M., Giacosa, A., Orsini, F., Opizzi, A., Villani, S., Appetite control and glycaemia reduction in overweight subjects treated with a combination of two highly standardized extracts from Phaseolus vulgaris and Cynara scolymus. Phytother. Res. 25:9 (2011), 1275–1282.
16. Zan, M.A., Ferraz, A.B., Richter, M.F., Picada, J.N., de Andrade, H.H., Lehmann, M., et al. In vivo genotoxicity evaluation of an artichoke (Cynara scolymus L.) aqueous extract. J. Food Sci. 78:2 (2013), T367–T371.
17. Eckel, R.H., Alberti, K.G., Grundy, S.M., Zimmet, P.Z., The metabolic syndrome. Lancet (London, England) 375:9710 (2010), 181–183.
18. Suzuki, T., Zeng, Z., Zhao, B., Wei, Z., Tanabe, M., Shimbo, T., et al. Comparison of coronary heart disease risk among four diagnostic definitions of metabolic syndrome. J. Endocrin. Invest. 39:11 (2016), 1337–1346.
19. Barter, P.J., Brewer, H.B., Chapman, M.J., Hennekens, C.H., Rader, D.J., Tall, A.R., Cholesteryl ester transfer protein a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 23:2 (2003), 160–167.
20. Sandhofer, A., Kaser, S., Ritsch, A., Laimer, M., Engl, J., Paulweber, B., et al. Cholesteryl ester transfer protein in metabolic syndrome. Obesity 14:5 (2006), 812–818.
21. Boekholdt, S., Sacks, F., Jukema, J., Shepherd, J., Freeman, D., McMahon, A., et al. Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment individual patient meta-analysis of 13 677 subjects. Circulation 111:3 (2005), 278–287.
22. Thompson, A., Di Angelantonio, E., Sarwar, N., Erqou, S., Saleheen, D., Dullaart, R.P., et al. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA 299:23 (2008), 2777–2788.
23. Povel, C., Boer, J., Reiling, E., Feskens, E., Genetic variants and the metabolic syndrome: a systematic review. Obes. Rev. 12:11 (2011), 952–967.
24. Rezazadeh, K., Rahmati-Yamchi, M., Mohammadnejad, L., Ebrahimi-Mameghani, M., Delazar, A., Effects of artichoke leaf extract supplementation on metabolic parameters in women with metabolic syndrome: influence of TCF7L2-rs7903146 and FTO-rs9939609 polymorphisms. Phytother. Res. PTR, 2017, 10.1002/ptr.5951 (in press).
25. Alberti, K., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., et al. Harmonizing the metabolic syndrome a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120:16 (2009), 1640–1645.
26. Azizi, F., Hadaegh, F., Khalili, D., Esteghamati, A., Hosseinpanah, F., Delavari, A., et al. Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch. Iran. Med. 13:5 (2010), 426–428.
27. LaGow, B., PDR for Herbal Medicines. 2004, Thomsin PDR publication, Mantvale, 44–46.
28. Ghasemi Dehkordi, A., Iranian Herbal Pharmacopeia (in Persian), Vol 1–2, 2002, Ministry of Health, Treatment and Medical Training publication, Tehran Iran.
29. Committee IR, Guidelines for Data Processing and Analysis of the International Physical Activity Questionnaire (IPAQ)-short and Long Forms. 2008 Retrieved September 17 (2005).
30. Craig, C.L., Marshall, A.L., Sjöström, M., Bauman, A.E., Booth, M.L., Ainsworth, B.E., et al. International physical activity questionnaire: 12-country reliability and validity. Med. Sci. Sports Exerc. 35:8 (2003), 1381–1395.
31. Friedewald, W.T., Levy, R.I., Fredrickson, D.S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18:6 (1972), 499–502.
32. Farid, M.A.K., Azizi, F., Hedayati, M., Daneshpour, M.S., Shamshiri, A.R., Siassi, F., Association between CETP Taq1B and LIPC-514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study. Lipids Health Dis., 9(1), 2010, 96.
33. Shimoda, H., Ninomiya, K., Nishida, N., Yoshino, T., Morikawa, T., Matsuda, H., et al. Anti-hyperlipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): structure requirement and mode of action. Bioorg. Med. Chem. Lett. 13:2 (2003), 223–228.
34. Küçükgergin, C., Aydın, A.F., Özdemirler-Erata, G., Mehmetçik, G., Koçak-Toker, N., Uysal, M., Effect of artichoke leaf extract on hepatic and cardiac oxidative stress in rats fed on high cholesterol diet. Biol. Trace Elem. Res. 135:1–3 (2010), 264–274.
35. Qiang, Z., Lee, S.O., Ye, Z., Wu, X., Hendrich, S., Artichoke extract lowered plasma cholesterol and increased fecal bile acids in Golden Syrian hamsters. Phytother. Res. 26:7 (2012), 1048–1052.
36. Van Venrooij, F.V., Stolk, R.P., Banga, J.-D., Sijmonsma, T.P., van Tol, A., Erkelens, D.W., et al. Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes. Diabetes Care 26:4 (2003), 1216–1223.
37. Daneshpour, M.S., Hedayati, M., Azizi, F., TaqI B1/B2 and-629A/C cholesteryl ester transfer protein (CETP) gene polymorphisms and their association with CETP activity and high-density lipoprotein cholesterol levels in a Tehranian population. Part of the Tehran Lipid and Glucose Study (TLGS). Genet. Mol. Biol. 30:4 (2007), 1039–1046.
38. Elsammak, M.Y., Al-Sharkaweey, R.M., Fahmy, M., Reda, A.A., Farid, W., Emara, A., et al. Taq 1B polymorphism of cholesteryl ester transfer protein (CETP) in Egyptian patients with metabolic syndrome. Diab. Metab. Syndrome: Clin. Res. Rev. 5:2 (2011), 61–65.
39. Hassanzadeh, T., Firoozrai, M., Zonouz, A.E., Zavarehee, A., Paoli, M., Taq1B polymorphism of cholesteryl ester transfer protein (CETP) gene in primary combined hyperlipidaemia. Indian J. Med. Res. 129:3 (2009), 293–298.
40. Estévez-González, M.D., Saavedra-Santana, P., López-Ríos, L., Chirino, R., Cebrero-García, E., Pena-Quintana, L., et al. HDL cholesterol levels in children with mild hypercholesterolemia: effect of consuming skim milk enriched with olive oil and modulation by the TAQ 1B polymorphism in the CETP gene. Ann. Nutr. Metab. 56:4 (2010), 288–293.
41. Gammon, C.S., Minihane, A.M., Kruger, R., Conlon, C.A., von Hurst, P.R., Jones, B., et al. TaqIB polymorphism in the cholesteryl ester transfer protein (CETP) gene influences lipid responses to the consumption of kiwifruit in hypercholesterolaemic men. Br. J. Nutr. 111:06 (2014), 1077–1084.
42. Ordovas, J.M., Cupples, L.A., Corella, D., Otvos, J.D., Osgood, D., Martinez, A., et al. Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk the framingham study. Arterioscler. Thromb. Vasc. Biol. 20:5 (2000), 1323–1329.